Navigation Links
New 'implanted contacts' designed to fix nearsightedness

UT Southwestern Medical Center ophthalmologists will be the first in the area to insert a new type of implanted lens to fix nearsightedness.

"Think of it as a contact lens inside your eye," said Dr. Wayne Bowman, who is inserting the new implantable collamer lens, or ICL, today for the first time at UT Southwestern University Hospitals.

The ICL can replace or reduce the need for glasses by permanently placing the specially fitted artificial lens in front of the eye's natural lens, rather than replacing the natural lens as other implanted lens do, said Dr. Bowman, professor of ophthalmology.

The lens, made of a special collamer material, corrects moderate to severe nearsightedness, known as myopia, by bending light rays to improve blurry distance vision without the need for glasses or contacts.

Dr. Bowman said the lens currently is approved only for nearsightedness, but it may eventually be available for farsightedness and astigmatism. It has been used for nearsightedness for several years in Europe and was approved by the Food and Drug Administration in December.

According to the FDA, a clinical study of 294 implanted patients showed that 95 percent ?279 patients ?had 20/40 or better vision, which is considered the standard needed for an unrestricted driver's license. And 59 percent ?almost 175 patients ?had 20/20 or better vision after three years.

Ideal candidates are typically under 40 years of age and don't yet have presbyopia, which makes reading glasses necessary, and whose corrections are outside the parameters for routine laser procedures, said Dr. Steven Verity, associate professor of ophthalmology, who specializes in refractive corneal surgery.

Rather than reshaping the eye, as in laser surgery, or replacing the eye's natural lens, as with intraocular lenses, the collamer lens is inserted with a smaller incision. Th e lens is like a fixed contact, but it can be removed if need be.

The procedure, Dr. Bowman said, normally takes about 10 to 15 minutes, and the patient sees the improvement soon after.


'"/>

Source:UT Southwestern Medical Center


Related biology news :

1. Medical molecules designed to respond to visible light that can penetrate tissue
2. Redesigned protein accelerates blood clotting
3. Intelligently designed molecular evolution
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
(Date:3/1/2016)... FRANCISCO , March 1, 2016  (RSAC Booth ... year, but a whopping $118 billion is lost to ... to overzealous and inaccurate fraud detection. At the RSA ... in the way companies handle authentication by devaluing the ... and behavioral analytics. --> ...
(Date:2/26/2016)... 2016 http://www.researchandmarkets.com/research/3f9fpr/biometrics_market ) ... "Biometrics Market in MENA: Research Report, Trends, ... offering. --> http://www.researchandmarkets.com/research/3f9fpr/biometrics_market ) ... "Biometrics Market in MENA: Research Report, Trends, ... offering. --> Research and ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Martine ... United Therapeutics will provide an overview and update on ... Annual Health Care Conference. The presentation ... 10:00 a.m. Eastern Time, and can be accessed via ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan ... affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology ... disorders and the suppression of graft vs. host disease (GVHD) under UM Professor Robert ...
(Date:4/26/2016)... (PRWEB) , ... April 26, 2016 , ... ... today announced that Ardy Arianpour has joined the company as Chief Business Officer. ... experience bringing innovative genomic technologies to market, was most recently Chief Commercial Officer ...
(Date:4/26/2016)... MD (PRWEB) , ... April 26, 2016 , ... ... a $1.8M Series A round of financing. Healthy investor interest drove significant oversubscription ... portfolio of generic biologics, known as biosimilars, to the advanced preclinical stages. , Chief ...
Breaking Biology Technology: